The inhibitor for TGF‐β1 receptor in this study sufficiently reverses the TGF‐β‐ and/or MMP‐9 induced the increased invasive abilities of the breast cell lines supplies further evidences supporting that TGF‐β/SMAD signalling increases malignancy of the cultured breast cancer cells. This evidence concerns the gene MMP9 and breast carcinoma.